← Back to Search

Guided Meditation for Postoperative Recovery

N/A

Waitlist Available

Led By Balachundhar Subramaniam, MD, MPH

Research Sponsored by Beth Israel Deaconess Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline and 1 month postoperatively

Awards & highlights

Study Summary

This trial is testing if a meditation program can help people before and after surgery.

Who is the study for?

This trial is for adults aged 18 or older who are scheduled to undergo certain types of heart surgery, including bypass grafts, valve surgeries, or aortic surgeries. The surgery must be planned at least two weeks after joining the study.Check my eligibility

What is being tested?

The study is examining how well meditation can work as an extra treatment to help patients recover after their heart surgery. Participants will follow a guided meditation program during the period around their operation.See study design

What are the potential side effects?

Since this trial involves meditation, there aren't typical medical side effects. However, participants might experience relaxation-related sensations such as drowsiness or emotional responses.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline and 1 month postoperatively

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline and 1 month postoperatively

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 1 month postoperatively for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Adherence to implementing a meditation program in the perioperative period

Secondary outcome measures

Biomarkers of inflammation

Changes in Sleep - PROMIS

Changes in Sleep - PSQI

+3 more

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: Group 2Experimental Treatment1 Intervention

Meditation twice daily for four weeks after surgery

Group II: Group 1Experimental Treatment1 Intervention

Meditation twice daily for at least two weeks prior to surgery and for four weeks after surgery

Group III: Group 3Active Control1 Intervention

Control group - will undergo surgery and subsequent hospital stay according to the current standard of care, which does not include meditation

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Meditation

2021

Completed Phase 3

~2740

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Beth Israel Deaconess Medical CenterLead Sponsor

836 Previous Clinical Trials

13,010,306 Total Patients Enrolled

Balachundhar Subramaniam, MD, MPHPrincipal InvestigatorBeth Israel Deaconess Medical Center

7 Previous Clinical Trials

9,806 Total Patients Enrolled

Media Library

Meditation Clinical Trial Eligibility Overview. Trial Name: NCT03198039 — N/A

Meditation Program Perioperatively Research Study Groups: Group 1, Group 2, Group 3

Meditation Program Perioperatively Clinical Trial 2023: Meditation Highlights & Side Effects. Trial Name: NCT03198039 — N/A

Meditation 2023 Treatment Timeline for Medical Study. Trial Name: NCT03198039 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any openings in this clinical research for participants?

"Unfortunately, per the clinicaltrials.gov records, this trial is no longer accepting candidates - it was first posted on November 28th 2017 and last updated February 14th 2022. Nevertheless, there are other trials currently recruiting patients at this time."

Answered by AI